VerityRank
Gansu Zongxing Mushroom Technology Co., Ltd.
Brand VerifiedChina

Gansu Zongxing Mushroom Technology Co., Ltd.

Zongxing Mushroom

Gansu Zongxing Mushroom Technology Co., Ltd. is a Chinese industrialised grower of enoki and button mushrooms, trading under the brand Zongxing Mushroom. Founded in 2005 and headquartered in the national agricultural science and technology park in Tianshui, Gansu Province, it grows both crops in climate-controlled rooms, formulates its own substrate and runs its own spawn breeding, and sells fresh mushrooms across China. It is listed on the main board of the Shenzhen Stock Exchange under code 002772. Gansu Zongxing Mushroom Technology is not a Fortune Global 500 company; revenue of about US$295 million in 2025 is far below the threshold used for the 2025 list.

The company was established in 2005 in Gansu, a north-western province where cool conditions and cheap land made industrialised cultivation viable, and it began with enoki mushrooms grown in bottles in insulated rooms. The second crop, the agaricus button mushroom, was added later and is produced on a composting rather than a bottle system, so the company now runs two different technologies side by side. Expansion since then has been geographic: bases were built in Shaanxi, Shandong, Jiangsu, Sichuan and Anhui, and a joint venture project took the business outside China for the first time, to Poland.

The fresh product range is narrow and deliberate. Enoki is the larger line, sold in consumer packs and in bulk for food service and hotpot-style catering, and button mushrooms form the second pillar, supplying the retail and processing markets that Western-style mushrooms serve in China. Spawn and strain breeding sit upstream and are treated as a business in their own right. The company also formulates its own growing substrate from liquid spawn fermentation onwards, which keeps the two most failure-prone steps of industrialised cultivation, the culture and the medium, inside the company.

Production runs through 16 modern production bases. Annual capacity exceeds 360,000 tonnes, with button mushrooms at roughly 300 tonnes a day and enoki above 700 tonnes a day. Rooms are intelligently controlled and the process from substrate mixing to harvest is scheduled rather than seasonal, so output is stable through the year and quality is repeatable enough for supermarket programmes. Because the bases are distributed across six provinces, freight distances to the main consumption regions are shorter than they would be from a single mega-site, but each location carries its own fixed overhead.

Revenue for 2025 was RMB 2.098 billion, about US$295 million, up 8.43 per cent year on year, with net profit attributable to shareholders of RMB 335 million. Edible mushrooms account for about 99 per cent of sales, the purest category focus on this page. The company operates in 2 countries, China and the Poland joint venture project, and employed about 3,800 people. Trading held up into 2026, with first-half revenue of RMB 1.085 billion, suggesting that the cost and utilisation advantages behind the 2025 result persisted into the following period.

The financial performance is the strongest of the Chinese producers here: a company that earned RMB 335 million in 2025 while a larger domestic rival was recovering from a loss of RMB 617 million, and it did so on roughly a third of that rival's revenue. The risks are execution and price. Some new production lines have had their construction schedules adjusted slightly by local planning requirements, so the timing of capacity additions is not entirely within the company's control, and both of its crops are commodities whose prices move with national supply. A grower with 99 per cent of revenue in mushrooms has no other business to absorb a price trough.

Read More
ChinaFounded 2005~3,800RMB$2.1 B / ~US$295m , up…16 production bases / 100
Listed onSZSE002772
Last updated: 2026-11-21 17:10 ET·By VerityRank Research Team·Methodology

Listed market data

002772 · SZSE · weeklyHistory →
Market cap
$393 M
Share price
CNY 7.01
1Y change
-40.7%
Recent change
-4.0%

11-19 → 11-20

IPO price
-7.8%

CNY 13.00 · from 2015-06-26

Revenue (TTM)
RMB$2.1 B / ~US$295m (2025), up 8.43% year on year
· updated 2026-11-21 17:10 ETSource ↗

Financial history

Full market history
CNY 0.0$0CNY 5.0$375 MCNY 10.0$750 MCNY 15.0$1.13 BCNY 20.0$1.5 B2025-122026-012026-022026-032026-042026-052026-062026-072026-082026-092026-102026-11
MonthCloseMarket capChange
  • 2026-11CNY 7.01$393 M-7.4%
  • 2026-10CNY 7.57$425 M-28.4%
  • 2026-09CNY 10.58$594 M-10.3%
  • 2026-08CNY 11.80$662 M+15.2%
  • 2026-07CNY 10.24$575 M-9.9%
  • 2026-06CNY 11.36$638 M-15.5%
  • 2026-05CNY 13.44$754 M-22.0%
  • 2026-04CNY 17.24$968 M+8.2%
  • 2026-03CNY 15.94$895 M-13.2%
  • 2026-02CNY 18.37$1 B+11.9%
  • 2026-01CNY 16.41$921 M+12.5%
  • 2025-12CNY 14.59$819 M—
Monthly closes · 2025-12 – 2026-11 · Full market history

Ownership & Control

Latest available filings
Controlling entity
Publicly held — no controlling shareholder disclosed
Company type
Brand
Insiders
45.41%
Institutions
6.86%(52 holders)
Free float
12.56%

Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.

Zongxing Mushroom is the most profitable company on this page relative to its size. It grows only two crops, sells almost nothing that is not a mushroom, and still earned a solid profit in a year when a larger Chinese rival was climbing out of a heavy loss. It ranks fifth on that combination of focus and margins rather than on absolute scale.

Industry Position

Sixteen production bases give the company annual capacity above 360,000 tonnes, split between two cultivation systems: enoki in bottles at more than 700 tonnes a day, and agaricus button mushrooms on compost at roughly 300 tonnes a day. Running both technologies is unusual, and it is the main reason the group is not dependent on a single price cycle the way single-crop growers are. Button mushrooms also open the retail and processing trade that enoki does not reach, so the two lines are sold through overlapping but distinct channels.

Revenue reached RMB 2.098 billion in 2025, about US$295 million, up 8.43 per cent, and edible mushrooms account for about 99 per cent of sales, the highest category purity in this ranking. Net profit attributable to shareholders was RMB 335 million. First-half 2026 revenue of RMB 1.085 billion suggests the pattern held, and about 3,800 people are employed across the group. Because the company is listed on the main board of the Shenzhen Stock Exchange, these figures come from public filings rather than private estimates, which is not the case for several larger competitors on this page.

Competitive Advantages

The dual-crop structure is the first advantage. Enoki and button mushrooms use different substrates, different rooms and different end markets, so when one category weakens the other can carry more of the load; competitors concentrated in enoki alone experienced the opposite in the years when that market was oversupplied nationally.

The second is vertical control of the biology. Spawn breeding and liquid fermentation are handled internally, and substrate is formulated by the company rather than bought, which puts the two steps most likely to destroy a crop cycle under its own quality systems. That combination, with high capacity utilisation, is what produced RMB 335 million of profit on a revenue base where larger rivals were barely breaking even.

Strategic Expansion

Growth is being pursued through capacity rather than acquisition. New production lines are under construction across the existing provincial network, which spreads volume closer to demand and reduces refrigerated transport distances, and the company keeps adding to a base count that already spans Gansu, Shaanxi, Shandong, Jiangsu, Sichuan and Anhui.

The second direction is international. A joint venture project in Poland is the company's first production outside China, and it is a test of whether a model built on Chinese provincial economics, cheap land, controlled rooms and local demand, can be repeated in a European cost environment where labour and energy are far more expensive.

Risks & Outlook

Execution of the capital programme is the nearer risk. Construction schedules for some new production lines have been adjusted slightly by local planning requirements, so capacity that has been budgeted and announced can arrive later than intended, and a delay while depreciation and staffing are already in place works directly against the 2025 margin.

The other exposure is price. Both of the company's crops are commodities traded on national supply and demand, and with about 99 per cent of revenue in edible mushrooms there is no second business to cushion a weak year. Gansu Zongxing Mushroom Technology is not a Fortune Global 500 company. On this page's weightings the purity, the margin and the two-crop platform justify fifth place. VerityRank Score of 85/100.

Quick Facts

Headquarters

National Agricultural Science and Technology Park, Tianshui, Gansu, China

Founded

2005

Employees

~3,800

Revenue

RMB$2.1 B / ~US$295m (2025), up 8.43% year on year

Market cap

$393 M

Factories

16 production bases (Gansu, Shaanxi, Shandong, Jiangsu, Sichuan, Anhui)

Presence

2 countries (China; Poland joint venture project)

Listing

Shenzhen Stock Exchange Main Board: 002772
Categories

Related

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , Zongxing Corporate Site · Zongxing Growth Analysis · Zongxing 002772 Earnings · Button Mushroom Revenue Share · Edible Mushroom Market · Mushroom Market Trends